Poniard Pharmaceuticals

PARD · OTC

$0.0001+$0.00 (+0.00%)TodayMarket closed · Oct 13, 8:02 AM ET

No price history for this range.

About PARD

Poniard Pharmaceuticals, Inc. is a bio-pharmaceutical company, which focuses on the development and commercialization of oncology products. The company is headquartered in Seattle, Washington and currently employs 7 full-time employees. The company went IPO on 2011-12-30. The firm focuses on the development and commercialization of oncology products to impact the lives of people with cancer. The company develops picoplatin, a platinum-based chemotherapeutic agent that is in clinical development for multiple cancer indications, treatment combinations and by two routes of administration. The firm has offices in San Francisco, California; and Seattle, Washington in United States.

Employees: 7
Headquarters: Seattle, Washington
Listed: Dec 30, 2011
Sector: Health Care
Industry: Biotechnology

Leadership

Poniard Pharmaceuticals executives
Name	Title	Since	Age
Ronald Martell	—	2006	60
Robert Basso	—	—	67
Frederick Craves	—	1993	76
Carl Goldfischer	—	—	63
Robert Littauer	—	—	56
David Stevens	—	—	73

Similar companies

Companies in the same industry as Poniard Pharmaceuticals

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.